Characteristics of the Intestinal Microbiota in Patients With Cancer

NACompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

February 6, 2017

Primary Completion Date

February 6, 2017

Study Completion Date

July 5, 2018

Conditions
Oncology
Interventions
BIOLOGICAL

Collection of stool and serum samples

"During the inclusion visit (for the 5 cancer sites): Stool collection (1 tube RNA later + 1 tube DMQO-EDTA) +Blood sample (1 tube SST + 1 tube EDTA)~1 month after treatment (only for non-small cell lung cancer): Stool collection (1 tube RNA later + 1 tube DMQO-EDTA) + Blood sample (1 tube SST + 1 tube EDTA)"

Trial Locations (2)

21079

Centre Georges-François Leclerc, Dijon

94800

Hopital Universitaire Paul Brousse, Villejuif

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Enterome

INDUSTRY

lead

Centre Georges Francois Leclerc

OTHER

NCT03196609 - Characteristics of the Intestinal Microbiota in Patients With Cancer | Biotech Hunter | Biotech Hunter